Analgesics in Japan

Table of Contents

Analgesics in Japan
Euromonitor International
May 2009
List of Contents and Tables
Executive Summary
Maturity Produces Slow Growth
Government Encourages Self-medication
Domestic Companies Dominate
Distribution Remains Restricted
Shrinking Sales Over the Forecast Period
Key Trends and Developments
Demographic Changes Shape Consumer Demand
Government Focuses on Reducing Medical Costs
Men' s Health
Strong Players Face Challenges Through Mergers
Distribution on the Brink of Expansion
Market Indicators
Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 2 Life Expectancy at Birth 2003-2008
Market Data
Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 5 OTC Healthcare Company Shares by Value 2004-2008
Table 6 OTC Healthcare Brand Shares by Value 2005-2008
Table 7 Penetration of Private Label by Sector 2003-2008
Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
Appendix
OTC Registration and Classification
Self-medication and Preventative Medicine
Generics
Switches
Summary 1 OTC Healthcare Switches 2005-2008
Definitions
Summary 2 Research Sources
Daiichi Sankyo Co Ltd
Strategic Direction
Key Facts
Summary 3 Daichi Sankyo Co Ltd: Key Facts
Company Background
Production
Competitive Positioning
Summary 4 DaiichiSankyo Group: Competitive Position 2008
Eisai Co Ltd
Strategic Direction
Key Facts
Summary 5 Eisai Co Ltd: Key Facts
Summary 6 Eisai Co Ltd: Operational Indicators
Production
Competitive Positioning
Summary 7 Eisai Co Ltd: Competitive Position 2008
Hisamitsu Pharmaceutical Co Inc
Strategic Direction
Key Facts
Summary 8 Hisamitsu Pharmaceutical Co Inc: Key Facts
Summary 9 Hisamitsu Pharmaceutical Co Inc: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 10 Hisamitsu Pharmaceutical Co Inc: Competitive Position 2008
Lion Corp
Strategic Direction
Key Facts
Summary 11 Lion Corp: Key Facts
Summary 12 Lion Corp: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 13 Lion Corp: Competitive Position 2008
Miki Corp
Strategic Direction
Key Facts
Summary 14 Miki Corp: Key Facts
Company Background
Production
Summary 15 Miki Corp: Production Statistics 2008
Competitive Positioning
Summary 16 Miki Corp: Competitive Position 2008
Rohto Pharmaceutical Co Ltd
Strategic Direction
Key Facts
Summary 17 Rohto Pharmaceutical Co Ltd: Key Facts
Summary 18 Rohto Pharmaceutical Co Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 19 Rohto Pharmaceutical Co Ltd: Competitive Position 2008
Sahto Pharmaceutical Co Ltd
Strategic Direction
Key Facts
Summary 20 Sato Pharmaceutical Co Ltd: Key Facts
Company Background
Production
Competitive Positioning
Summary 21 Sato Pharmaceutical Co Ltd: Competitive Position 2008
Ssp Co Ltd
Strategic Direction
Key Facts
Summary 22 SSP Co Ltd: Key Facts
Summary 23 SSP Co Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 24 SSP Co Ltd: Competitive Position 2008
Taisho Pharmaceutical Co Ltd
Strategic Direction
Key Facts
Summary 25 Taisho Pharmaceutical Co Ltd: Key Facts
Summary 26 Taisho Pharmaceutical Co Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 27 Taisho Pharmaceutical Co Ltd: Competitive Position 2008
Takeda Chemical Industries Ltd
Strategic Direction
Key Facts
Summary 28 Takeda Chemical Industries Ltd: Key Facts
Summary 29 Takeda Chemical Industries Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 30 Takeda Chemical Industries Ltd: Competitive Position 2008
Headlines
Trends
Switches
Competitive Landscape
Prospects
Sector Data
Table 12 Sales of Analgesics by Subsector: Value 2003-2008
Table 13 Sales of Analgesics by Subsector: % Value Growth 2003-2008
Table 14 Herbal vs Standard Topical Analgesics 2003-2008
Table 15 Topical Analgesics by Format: % Value Breakdown 2004-2008
Table 16 Analgesics Company Shares by Value 2004-2008
Table 17 Analgesics Brand Shares by Value 2005-2008
Table 18 Forecast Sales of Analgesics by Subsector: Value 2008-2013
Table 19 Forecast Sales of Analgesics by Subsector: % Value Growth 2008-2013